Thank you!

With thanks to @imranahmed.bsky.social

This is a followup to our previous investigation into Minicircle and the Honduran economic free zone, Próspera, made with @basialc.bsky.social, which you can listen to here: open.spotify.com/episode/5jTz...

Huge thanks to producer Madeleine Parr who was instrumental in shaping such a complex narrative, to our editors @jaspercorbett.bsky.social and @mattrussell3.bsky.social, and sound designer @domdelargy.bsky.social

You can also find it on Apple podcasts:
podcasts.apple.com/gb/podcast/t...

You can listen to my latest podcast, The immortality bros: the new frontiers of health here on Spotify, or on any podcasting platform:
open.spotify.com/episode/3J7b...

Supporters say this could speed up life-changing research. Critics warn it risks bypassing safeguards and harming more people than it helps.

And if it works, it could set a new norm: one where patients, not regulators, decide how much risk to take

In May, the state of Montana broadened its “right-to-try” legislation.

Since 2014, terminally ill patients could apply to use treatments that hadn’t yet cleared the FDA. Now, even healthy patients can apply to try unproven “life-extending” drugs

What began as the story of one company turned into something larger: the rise of a “longevity” industry that is no longer confined to a handful of wealthy experimenters but is edging towards the American mainstream